Rhabdomyolisis – a clinical case study and brief theoretical revision

Authors

  • José N. Raposo Médico do Internato Complementar de Medicina Interna, Serviço de Medicina do Hospital Garcia de Orta, Lisboa
  • Alexandre João Médico do Internato Complementar de Dermatologia, Serviço de Medicina do Hospital Garcia de Orta, Lisboa
  • João Namora Assistente Hospitalar Graduado de Medicina Interna, Serviço de Medicina do Hospital Garcia de Orta, Lisboa
  • Álvaro de Carvalho Chefe de Serviço de Medicina Interna, Serviço de Medicina do Hospital Garcia de Orta, Lisboa

Keywords:

rhabdomyolysis, antilipemic drugs

Abstract

The authors report the case of a 54 year-old patient
with rhabdomyolysis secondary to an anti-lipaemic drug.
High levels of creatine kinase and myoglobin, as
well as increased concentrations of aspartate
transaminase and alanine transaminase, lead to the
diagnosis. In spite of those laboratory findings,
severe renal insufficiency did not occur, probably
because of early treatment. A review of the literature
on this subject is also presented.

Downloads

Download data is not yet available.

References

Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000; 11: 1553 - 1561.

Gabow PA, Haehny WD, Kelleher SP. The Spectrum of Rhabdomyolysis. Medicine 1982; 61: 141-152.

Miller ML. Rhabdomyolysis. 2000 Up to Date Inc (800). 998 - 6374 : (781)237-4788.

Better OS, Stein JH. Early management of schock and prophylaxis of renal failure in thraumatic rhabdomyolysis. N Eng J Med 1990.

;322(12):825-829.

Odeh M. The role of reperfusion-induced injury in the pathogenisis of the Crush-syndrome. N Eng J Med 1991; 324(20):1417-1422.

Guzé BH, Baxter LR. Neuroleptic Malignant Syndrome. N Eng J Med 1985; 313(3): 163-166.

Marais GE, Larson KK. Rhabdomyolysis and acute renal failure induced by combination of lovastatin and gemfibrozil therapy. Ann

Intern Med 1990;112: 228-230.

Knochel JP. Mechanisms of Rhabdomyolysis. Current Op Rheum1993;5:725-731.

Knochel JP, Moore GE. Rhabdomyolysis in malaria. N Eng J Med 1993; 329: 1206.

Woolfson RG, Hillman K. Causes of Acute Renal Failure. in Comprehensive Clinical Nephrology. Harcourt Publishers

Limited,1st Ed 2000;16:16.8-16.11.

Ron D, Taitelman U, Michalson M, Bar-Joseph G, Bursztein S, Better OS. Prevention of acute renal failure in thraumatic

rhabdomyolysis. Arch Intern Med 1984; 144: 277-280.

Murdock DK, Murdock AK, Murdock RW et al. Long-term safety and efficacy of combination gemfibrozil and HMG-Co A reductase

inhibitors for the treatment of mixed lipid disorders. Am Heart J 1999;138:151-158.

Pogson GW, Kindred LH, Carper BG. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination

therapy. Am J Cardiol 1999; 83: 1146.

Beaird SL. HMG-Co A Reductase inhibitors: Assessing Differences in Drug Interactions and Safety Profiles. J Am Pharm Assoc

;40(5): 637-644.

Gemici G, Toprak A, Oktay A. Rhabdomyolysis due to cerivastatin monotherapy. Am J Med 2000; 110 (9): 742

Additional Files

Published

2002-06-28

How to Cite

1.
Raposo JN, João A, Namora J, de Carvalho Álvaro. Rhabdomyolisis – a clinical case study and brief theoretical revision. RPMI [Internet]. 2002 Jun. 28 [cited 2024 Dec. 18];9(2):80-4. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1854

Issue

Vol. 9 No. 2 (2002): Abril/ Junho

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)